Madariaga AG, Palacios SS, Guillén-Grima F, Galofré JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 2014;99(3):923-31. https://doi.org/10.1210/jc.2013-2409

Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 2018;14(5):301-16. https://doi.org/10.1038/nrendo.2018.18

Zhang X, Wang X, Hu H, Qu H, Xu Y, Li Q. Prevalence and Trends of Thyroid Disease Among Adults, 1999-2018. Endocr Pract 2023;29(11):875-80. https://doi.org/10.1016/j.eprac.2023.08.006

Yadav NK, Thanpari C, Shrewastwa MK, Sathian B, Mittal RK. Socio demographic wise risk assessment of thyroid function abnormalities in far western region of Nepal: A hospital based descriptive study. Asian Pac J Trop Dis 2013;3(2):150-4. https://doi.org/10.1016/S2222-1808(13)60060-2

Azeez TA, Adetunji TA, Adio M. Thyrotoxicosis in Africa: a systematic review and meta-analysis of the clinical presentation. Egypt J Intern Med 2022;34:57. https://doi.org/10.1186/s43162-022-00145-5.

Reid JR, Wheeler SF. Hyperthyroidism: Diagnosis and treatment. Am Fam Physician 2005;72(4):623-30.

Subbiah K, Kumar J, Sivappriyan S, Anandappa S. Differentiating recurrent thyroiditis from Graves’ disease on a background of lithium use. J Endocr Soc 2021;5(Suppl 1):A927. https://doi.org/10.1210%2Fjendso%2Fbvab048.1894

Karndumri K, Thewjitcharoen Y, Chatchomchuan W, Porramatikul S, Krittiyawong S, Wanothayaroj E, et al. Impact of first-line treatment choice on long-term outcomes of hyperthyroid graves’ disease patients with thyrotoxic periodic paralysis. J Clin Transl Endrocr 2020;21:100235. https://doi.org/10.1016/j.jcte.2020.100235

Bhattarai AM, Pandeya D, Parajuli S, Pradhananga S. Pattern of thyroid illness in a tertiary hospital in Nepal. Med J Shree Birendra Hosp 2020;21(1):93-7. https://doi.org/10.3126/mjsbh.v21i1.39366

Ullah F, Ali SS, Tahir H. Clinical spectrum of thyroid disorders; An experience at a tertiary care hospital in Peshawar. Pak J Med Res 2022;61(2):56-62.

Alam Z, Shah M, Khan M, Ali W, Shehzad A, Shah JA, et al. Thyroid dysfunction and prevalence of both clinical and subclinical forms of hyperthyroidism and hypothyroidism in District Mardan, KPK, Pakistan. Bull Env Pharmacol Life Sci 2019;8(11):98-104.

Leo SD, Lee SY, Braverman LE. Hyperthyroidism. The Lancet 2016;388(10047):906-18. https://doi.org/10.1016/S0140-6736(16)00278-6

Pooria A, Pourya A, Gheini A. Frequency of pathological types of hyperthyroidism in thyroid scan patients. Curr Med Imaging 2021;17(5):608-12. https://doi.org/10.2174/1573405616666201118142752

Kuzmanovska S, Vaskova O. Interference in thyroid function immunoassays: Clinical consequences. Maced Pharm Bull 2020;66(1)73-8. https://doi.org/10.33320/maced.pharm.bull.2020.66.01.008

Abraham P, Avenell A, Park CM, Watson WA, Bevan JS. A systematic review of drug therapy for graves' hyperthyroidism. Eur J Endocr 2005;153(4):489-98. https://doi.org/10.1530/eje.1.01993

Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician 2016;93(5):363-70.

Ahn HY, Cho SW, Lee MY, Park YJ, Koo BS, Chang HS, et al. Prevalence, Treatment Status, and Comorbidities of Hyperthyroidism in Korea from 2003 to 2018: A Nationwide Population Study. Endocrinol Metab (Seoul) 2023;38(4):436-44. https://doi.org/10.3803/EnM.2023.1684

Akhter S, Khan A, Siddiqui MM, Nawab G. Frequencies of thyroid problems in different ages, sex and seasons. J Med Sci 2001;1:153-6. https://doi.org/10.1186/s12884-018-2059-8

Weihua W, Zhenjie S, Jiangpo Y, Qinghui M, Mingli W, Jiajing M. A clinical retrospective analysis of factors associated with apathetic hyperthyroidism. Pathobiology 2010;77(1):46-51. https://doi.org/10.1159/000272954

Iqbal MA, Naseem Z, Qureshy A, Shahid A, Roohi N. Prevalence and manifestations of thyroidal dysfunction in Central Punjab Pakistan (a case study). Sci Int (Lahore) 2016;28(4):3959-63.